Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by NB1017on Apr 05, 2019 11:09am
133 Views
Post# 29587534

RE:RE:RE:Thought newest NR would garner more attention...

RE:RE:RE:Thought newest NR would garner more attention...I agree 100% on their longevity and being a giant. If I were a Big Pharma company, I'd be watching Aurora very closely and keeping in the loop with Peltz and management for the right time to step in.
Auctioneer wrote: I have been holding ACB since just over a buck and I have not really noticed this trend, but you might be right.  I don't think they're trying to control the price.  I think the management view, and I agree, is that they are thinking long term.  There is no doubt in my mind that ACB will be around in twenty years and be a giant.  I think they have that mindset. 
NB1017 wrote: I've held and played Aurora ever since it was in the 50 cent range, and one thing I noticed they tend to do is release back to back to back news at important times.... Either to keep a rally going or in cases like now, to maintain valuation. If not for the recent news events, Aurora would likely be slipping to the $10-$11 range. Think of this as a good thing as they are going sideways; all it would take is partnership talks to begin and Aurora would surge to all time high. I
Rush09 wrote: The Company was awarded the maximum number of 5 of the 13 lots in the tender over a period of four years with a minimum supply of 4000kg total. The cannabis produced will be sold to the German government and supplied to wholesalers for distribution to pharmacies.

That is pretty big news.


 






Bullboard Posts